Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Entrada Therapeutics, Inc. (TRDA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,211,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Entrada Therapeutics is an intracellular therapeutics company. Endosomal Escape Vehicle (EEV) therapeutics are comprised of small cyclic peptides that are chemically conjugated to a range of specific and active biological therapeutics. Co.'s EEV therapeutics are designed to engage intracellular targets that have long been considered inaccessible and undruggable. Through its proprietary modular EEV platform, Co. is building a development portfolio of EEV therapeutic candidates designed to enable the intracellular delivery of therapeutics in various organs and tissues with an improved therapeutic index. Co. is focused on the development of EEV therapeutics for rare neuromuscular diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 45,368
Total Buy Value $0 $0 $0 $641,941
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 11
Total Shares Sold 1,784 1,784 186,264 332,637
Total Sell Value $19,035 $19,035 $3,567,171 $5,863,067
Total People Sold 1 1 6 7
Total Sell Transactions 1 1 29 62
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 277
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Wentworth Kory James Chief Financial Officer   •       –      –    2025-04-03 4 OE $2.10 $23,381 D/D 11,134 120,670     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2025-03-17 4 AS $10.67 $19,035 D/D (1,784) 109,536     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2025-03-03 4 D $11.68 $57,564 D/D (4,929) 111,320     -
   Dowden Nathan J President & COO   •       –      –    2025-03-03 4 D $11.68 $60,075 D/D (5,144) 180,805     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2025-03-03 4 D $11.68 $71,683 D/D (6,138) 199,659     -
   Doshi Dipal CEO   •       •      –    2025-03-03 4 D $11.68 $205,146 D/D (17,566) 424,387     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2025-03-01 4 A $0.00 $0 D/D 42,400 116,249     -
   Dowden Nathan J President & COO   •       –      –    2025-03-01 4 A $0.00 $0 D/D 60,800 185,949     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2025-03-01 4 A $0.00 $0 D/D 60,800 205,797     -
   Doshi Dipal CEO   •       •      –    2025-03-01 4 A $0.00 $0 D/D 116,200 441,953     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2024-12-11 4 S $20.23 $440,751 I/I (21,787) 4,381,062     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2024-12-11 4 S $20.23 $440,751 I/I (21,787) 4,381,062     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2024-12-10 4 S $20.77 $476,360 I/I (22,935) 4,402,849     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2024-12-10 4 S $20.77 $476,360 I/I (22,935) 4,402,849     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2024-12-03 4 AS $20.15 $235,786 D/D (11,703) 144,997     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-12-02 4 AS $20.00 $99,978 D/D (5,000) 73,849     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-12-02 4 OE $2.10 $10,500 D/D 5,000 78,849     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2024-12-02 4 AS $20.26 $82,834 D/D (4,088) 156,700     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-11-29 4 AS $19.97 $19,970 D/D (1,000) 73,849     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-11-29 4 OE $2.10 $2,100 D/D 1,000 74,849     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2024-11-29 4 AS $20.00 $2,000 D/D (100) 160,788     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2024-11-13 4 AS $20.04 $54,109 D/D (2,700) 160,888     -
   Sethuraman Natarajan President, Research & Develop.   •       –      –    2024-11-11 4 AS $20.01 $28,191 D/D (1,409) 163,588     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-11-11 4 AS $19.98 $172,562 D/D (8,637) 73,849     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-11-11 4 OE $2.10 $12,600 D/D 6,000 82,486     -

  277 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed